CORRIGENDUM: Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing.
Circulation reports（2023）
摘要
[This corrects the article DOI: 10.1253/circrep.CR-22-0076.].
更多查看译文
关键词
Anticoagulation monitoring,Atrial fibrillation,Edoxaban,Off-label dosing,Rivaroxaban
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要